TrialDiabetes, obesity & metabolism2026

Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III Trial.

Soo Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.